Merit Medical: Barrington Research Raises PT to $103 from $103, Maintains Outperform

Merit Medical: Barrington Research Raises PT to $103 from $103, Maintains Outperform

On September 12, 2025, Barrington Research issued a report updating its target price for Portillo's (NASDAQ: PTLO) stock. The investment research firm has maintained its "Outperform" rating while raising the price target to $103 from the previous $103. This move reflects a reassessment of the company's prospects despite the ongoing challenges in its core markets.

Portillo's, founded in 1963, operates as a casual restaurant chain specializing in Chicago-style hot dogs, beef sandwiches, fries, and shakes. The company has been facing weak same-store sales trends over the past two years, which have limited its growth opportunities. Additionally, the lack of free cash flow generation has constrained its ability to reinvest for growth, repurchase shares, or distribute capital. Furthermore, the company's unfavorable liquidity position could lead to additional equity financing, potentially diluting shareholders 3 Out-of-Favor Stocks We Find Risky^[1].

Despite these challenges, Barrington Research's updated target price suggests a positive outlook for the stock. The firm's analysis likely considers factors such as the company's established brand, customer loyalty, and potential for expansion into new markets. However, investors should remain cautious and conduct thorough due diligence before making investment decisions.

For more detailed information on Portillo's, investors can refer to StockStory's free research report, which provides a comprehensive analysis of the company's financial health and growth prospects.